NCT01979887View on ClinicalTrials.gov

Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Meibomian Glands
Interventions
PROCEDURE

Meibum Expression

Meibum expression as per protocol. No investigational drug is administered in this study.

Trial Locations (2)

Unknown

Houston

London

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01979887 - Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter